Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Research Insight Provides valuable insights into cellular senescence and the elimination of aged cells
LM22A-4 LM22A-4 is a tripeptide mimetic identified through in silico screening using a pharmacophore model based on BDNF loop domains
Originally developed for type 2 diabetes, Tirzepatide has quickly become one of the most effective compounds for body recomposition and fat loss, outperforming even Semaglutide in clinical trials
The listing includes one 10mg lyophilized retatrutide vial (98% purity per supplier batch specification), one 5ml vial of bacteriostatic water, two 3ml Luer-lock syringes for reconstitution, and five 1ml graduated syringes components supplied together for laboratory handling
You do not know what is in them
It could place them in Category 1, allowing them to be used in compounding
US$ 21.13
US$ 21.55
US$ 23.10
US$ 27.22
US$ 23.79